Solitary ideas without action
remain mere thoughts.
Yet, together, we can turn them
into meaningful change.
The Luskin
family foundation
Featured Initiative
Download Presentation
Our mission
Founded on the principles of improving health, healthcare access, reducing disparity and providing educational resources, our mission is to be the pathway that strengthens and supports state-of-the-art science research and education.
We think outside the box and are not bound by old methodology. We approach our projects by using a systems-thinking process; looking beyond the current state.
Support us
Thank you for your tax deductible donation.
The Luskin Family Foundation is a tax exempt
organization EIN#93-4348331
As a key driving force with the new era in reproductive research and technology, The Luskin Family Foundation is committed to supporting revolutionary solutions like this compassionate alternative to preserving life and empowering women’s health initiatives.
The new cutting-edge and scientifically sound research ensures a safe transfer of the embryo from the mother's body to a secure, nurturing, meticulously monitored environment. This revolutionary solution allows the continuation of pregnancy without the need for a surrogate, saving both time and money. Furthermore, in cases of an unintended pregnancy, instead of resorting to clinical termination, our technology offers the compassionate alternative to preserve the embryo's life and provide an opportunity for the child to be welcomed into a loving family.
We welcome you to support us and be a part of our Foundation’s effort to make this a reality.
Please mail checks to:
The Luskin Family Foundation
P.O. Box 831
Piedmont, SC 29673
Please mail checks to:
The Luskin Family Foundation
P.O. Box 831
Piedmont, SC 29673
Donate
The Luskin Family Foundation is a tax exempt
organization EIN#93-4348331
Donate
The Luskin Family Foundation is a tax exempt
organization EIN#93-4348331
Areas of interest
Focus I:
Women's and Children's
Health
Breast Cancer Research
Prevention of Sudden Infant Death Syndrome
Supporting women’s reproductive
health research
Pathogen Association
with common
diseases
Focus II:
Education and Talent
Nurture
Summer Science Camps
Regional Science Olympiads
Research Programs for High School Students
School Athletics Safety
and
Management
Focus III:
Behavioral Science and
Support
Prophylaxis of Alchohol and
Drug Use
Family Therapy Research
Child and Adolescent Mental
Health Support
AI Driven Healthy
Lifestyle Promotion/
Monitoring Research
Focus IV:
Public Health and Outreach
Excluding Insurance as a Middleman
for Healthcare Expenses
ai Applications for Public Health
Personalized AI Health
Advisor
Increasing Longevity
of Life
Where we are
Emerging South Carolina
life sciences hubs
With continued growth across the sector in the US, the competition
for life sciences business
is strong, with more biotech hubs emerging.
Thanks to continued investment and ongoing collaboration between educational institutions, research facilities and biotech companies, South Carolina is emerging as a genuine hub for the high-tech industry.
According to a report published by SCBIO, the trade association that represents the life sciences industry in South Carolina, in excess of 700 life sciences companies and businesses are currently investing and operating in the state.
With contributions from research facilities and institutions, there continues to be a concerted effort to drive economic development strategies, designed specifically to attract life sciences companies to start up, expand or relocate in South Carolina.
Donate
Thank you for your tax deductible donation.
The Luskin Family Foundation is a tax exempt
organization EIN#93-4348331
About us
Irina Luskin
BoD Member, President,
Clinical Consultant
(Woman's Health)
Irina Luskin graduated in 1974 from the Gorky State School of Medicine and then received an additional specialization in OB/GYN during residency in the largest regional hospital. From 1976 to 1985 she was a leading surgeon, performing all types of gynecological procedures and advancing her expertise ranging from emergency delivery procedures to pathology and analytics. In 1985 she started leading the largest OB/GYN department in the area, which in addition to planned and emergency medicine also was the platform for academic research. After moving to Israel in 1995, Irina successfully went through a lengthy process of re-certification to continue practicing medicine. Since 1998 she was employed by “Bnei Zion” hospital in Haifa, “Laniado” hospital in Netanya, and “Holy Family” hospital in Nazareth.
Cecilia Zapata-
Harms
BoD Member, VP,
Secretary
Cecilia Zapata-Harms' professional life includes entrepreneurial endeavors in the life sciences and healthcare field. She is passionate about global health access, innovative approaches to access novel treatments, especially for our rural communities, military, and rural/developing countries.
- 27+ years with Fred Hutchinson Cancer Research Center held leadership positions in strategy, affiliate network, and including Molecular Pharmacology Division Administrator
- Oversaw clinical research trials management for FHCRC nationally, in parts of Europe and Asia
- Part of the global health program and team that opened FHCRC Uganda Cancer Center
- Team member for FHCRC biotech startup and have deep relationships with scientific faculty researchers in
pharma companies like Merck,
Pfizer, Roche, GSK, Seagen,
Amgen, and others
with scientific faculty researchers in
pharma companies like Merck,
Pfizer, Roche, GSK, Seagen,
Amgen, and others
Svetlana Luskin
BoD Member,
Treasurer
Svetlana Luskin is a University of Washington graduate, with a degree in Mathematics and Computational Sciences. Throughout her professional journey, she has held various roles in both small enterprises and large corporations, including Microsoft. Her responsibilities have ranged from overseeing the seamless release of commercial products to refining customer workflows and managing expectations. Additionally, Svetlana has actively participated in non-profit educational organizations, supported multiple political campaigns, and contributed to fundraising efforts and positioning for healthcare and related projects. With a blend of technological proficiency, product knowledge, and customer-facing skills, Svetlana is a forward-thinking individual dedicated to fostering a balanced and promising future.
Eugene Luskin
Executive Director
Eugene Luskin is a co-founder and CEO of Sync.MD which specializes in providing a Personal Health Records platform and solutions to patients, providers, and research organizations. Eugene has over 12 years of CEO experience out of 25+ total years in the software, firmware, and hardware development industry. A computer science graduate from the University of Haifa (Israel), his technology background includes a variety of roles at large companies such as Microsoft, Intel, and Parametric as well as advisory and executive positions at several startups.
Alexey Vertegel
Director of Research
and Outreach
Alexey Vertegel the Associate Professor at Clemson University’s Department of Bioengineering. He holds a Ph.D. Degree In Inorganic chemistry from Moscow State
University. Alexey’s main research interests are:
- Protein-nanoparticle conjugate
- Fiber-based biosensors and biodevices
- Advanced scanning-probe-microscopy techniques
Erik Osborne
Director of Clinical
Research
Erik Osborne leads a startup company that aims to revolutionize the healthcare industry by making it more affordable, transparent, and efficient for all stakeholders. With over 10 years of combined experience in communication, counseling, medicine, and business. Erik has a unique multidisciplinary background that enables him to understand the needs and challenges of patients, providers, and payers, and to create innovative solutions that address them.
Pavel Prigolovko
Director of BizDev,
Communications,
and Marketing
Pavel Prigolovko possesses a rich and diverse background in venture projects, with a strong focus on both longevity and IT innovations. In the field of longevity, Pavel is known for his dedication to advancing medical research, biotechnology, and healthcare technologies, aiming to extend human lifespans and enhance well-being.
Ash Gupta
Advisor
Ash Gupta retired from American Express in 2018 after 40 years of continuous service and for many years was the company’s Chief Risk Officer. In this role, he led the company well through the Great Recession. Most recently, he served as the President of Global Credit Risk and Information management – a team of over 1,000 data scientists - bringing Big Data, Machine Learning and AI into Amex’ DNA across marketing, risk management and servicing. Earlier, he was the Chairman and CEO of the Company’s U.S. banks, overseeing $75+ billion assets.
Following retirement from American Express, Ash has taken a role in serving companies focused on Payments and AI. Currently, he is an Advisor to, Global Consulting firm - Oliver Wyman, Chair of Compensation Committee for Encore Capital Group (NASDAQ: ECPG); Chair (and co-founder) for Corridor Platforms Inc.; Board member, Tomo Credit. Previously, he served as a board member and Audit committee chair for Symphony Teleca Corporation (sold to Harman International in 2015).
Ash has an MBA from Columbia University and a B. Tech in engineering from IIT Delhi (distinguished
alumni, 2006). Ash serves on the boards for Big Brothers
and Big Sisters of New York, National Association of
Corporate Directors (New York Chapter). He and his wife
reside in New York City.
Daniel Luskin
Content Manager
and Art Director
Daniel Luskin is currently a high school sophomore in the southeastern US. He began experimenting with art in 2020, and throughout the past few years has evolved his skill for many different mediums and applications. Daniel aims to leverage his skills to create compelling and visually appealing content for the foundation, such as incorporating elements like creative infographics and pleasing animation. Moreover, he is committed to acquiring additional skills that will contribute to the seamless functioning of the entire movement, addressing both the external presentation and the internal mechanics.